Patients with MC accounted for a larger proportion of patients with stage III CRC (44.2%) than AC (29.9%, P < 0.001) and AMC (29.0%, P = 0.091); but for AMC, the difference is only marginally significant.
← all excerpts
Distinct Genomic Landscape of Colorectal Mucinous Carcinoma Determined <i>via</i> Comprehensive Genomic Profiling: Steps to a New Treatment Strategy.
1
—
—